Skip to main content

CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition.

Publication ,  Journal Article
Chang, TL-Y; François, F; Mosoian, A; Klotman, ME
Published in: J Virol
June 2003

CD8(+) T lymphocytes can inhibit human immunodeficiency virus type 1 (HIV-1) replication by secreting a soluble factor(s) known as CD8(+) T-lymphocyte antiviral factor (CAF). One site of CAF action is inhibition of HIV-1 RNA transcription, particularly at the step of long terminal repeat (LTR)-driven gene expression. The inhibitory effect of CAF on HIV-1 LTR activation is mediated through STAT1 activation. A recent study reports that alpha-defensins 1 to 3 account for CAF activity against HIV-1. Here, we address whether alpha-defensins, particularly alpha-defensin-1, contribute to CAF-mediated inhibition of HIV-1 transcription. Both recombinant alpha-defensin-1 and CAF derived from herpesvirus saimiri (HVS)-transformed CD8(+) cells inhibited HIV-1 infection and gene expression. For both factors, the inhibition of HIV-1 infection did not occur at the level of viral entry. Pretreatment of cells with alpha-defensin-1 followed by a washing out prior to infection blocked infection by HIV-1, indicating that direct inactivation of virions was not required for its inhibitory effect. In contrast to CAF, alpha-defensin-1 did not inhibit phorbol myristate acetate- or Tat-mediated HIV-1 LTR activation in a transient transfection system, nor did it activate STAT1 tyrosine phosphorylation. Furthermore, alpha-defensins 1 to 3 were below the level of detection in a panel of HVS-transformed CD8(+) cells with potent HIV-1 inhibitory activity and a neutralizing antibody against alpha-defensins 1 to 3 did not reverse the inhibitory effect of CAF on HIV-1 gene expression in infected cells and on HIV-1 LTR activation in transfected cells. Taken together, our results suggest that alpha-defensin-1 inhibits HIV-1 infection following viral entry but that alpha-defensins 1 to 3 are not responsible for the HIV-1 transcriptional inhibition by CAF.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Virol

DOI

ISSN

0022-538X

Publication Date

June 2003

Volume

77

Issue

12

Start / End Page

6777 / 6784

Location

United States

Related Subject Headings

  • alpha-Defensins
  • Virology
  • Transcription, Genetic
  • Macrophages
  • Humans
  • Hela Cells
  • HeLa Cells
  • HIV-1
  • HIV Infections
  • Gene Expression Regulation, Viral
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chang, T.-Y., François, F., Mosoian, A., & Klotman, M. E. (2003). CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition. J Virol, 77(12), 6777–6784. https://doi.org/10.1128/jvi.77.12.6777-6784.2003
Chang, Theresa Li-Yun, Fleur François, Arevik Mosoian, and Mary E. Klotman. “CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition.J Virol 77, no. 12 (June 2003): 6777–84. https://doi.org/10.1128/jvi.77.12.6777-6784.2003.
Chang, Theresa Li-Yun, et al. “CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition.J Virol, vol. 77, no. 12, June 2003, pp. 6777–84. Pubmed, doi:10.1128/jvi.77.12.6777-6784.2003.

Published In

J Virol

DOI

ISSN

0022-538X

Publication Date

June 2003

Volume

77

Issue

12

Start / End Page

6777 / 6784

Location

United States

Related Subject Headings

  • alpha-Defensins
  • Virology
  • Transcription, Genetic
  • Macrophages
  • Humans
  • Hela Cells
  • HeLa Cells
  • HIV-1
  • HIV Infections
  • Gene Expression Regulation, Viral